Mark Lackner is SVP, Head of Biology of IDEAYA Biosciences, Inc.. Currently has a direct ownership of 0 shares of IDYA, which is worth approximately $0. The most recent transaction as insider was on Feb 10, 2021, when has been sold 596 shares (Common Stock) at a price of $21.0 per share, resulting in proceeds of $12,516. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Mark Lackner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2021
SELL
Open market or private sale
$12,516 $21.0 p/Share
596 Reduced 100.0%
0 Common Stock
Feb 10 2021
BUY
Exercise of conversion of derivative security
$4,160 $6.98 p/Share
596 Added 50.0%
596 Common Stock
Feb 09 2021
SELL
Open market or private sale
$23,239 $21.05 p/Share
1,104 Reduced 100.0%
0 Common Stock
Feb 09 2021
BUY
Exercise of conversion of derivative security
$7,706 $6.98 p/Share
1,104 Added 50.0%
1,104 Common Stock
Feb 08 2021
SELL
Open market or private sale
$6,303 $21.01 p/Share
300 Reduced 100.0%
0 Common Stock
Feb 08 2021
BUY
Exercise of conversion of derivative security
$2,094 $6.98 p/Share
300 Added 50.0%
300 Common Stock
Jan 26 2021
SELL
Open market or private sale
$46,394 $18.55 p/Share
2,501 Reduced 100.0%
0 Common Stock
Jan 26 2021
BUY
Exercise of conversion of derivative security
$8,700 $5.8 p/Share
1,500 Added 37.49%
2,501 Common Stock

Also insider at

ZNTL
Zentalis Pharmaceuticals, Inc. Healthcare
ML

Mark Lackner

SVP, Head of Biology
South San Francisco, CA

Track Institutional and Insider Activities on IDYA

Follow IDEAYA Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDYA shares.

Notify only if

Insider Trading

Get notified when an Ideaya Biosciences, Inc. insider buys or sells IDYA shares.

Notify only if

News

Receive news related to IDEAYA Biosciences, Inc.

Track Activities on IDYA